PRSS22, which is upregulated by the E2F1 transcription factor, could directly combine with ANXA1 to promote ANXA1 cleavage that subsequently initiates FPR2-ERK cascades to improve the aggressiveness of BC cells (Fig. 6J). Here, FPR2 is linked to breast cancer.